Medicine
Pentobarbital 1000 mg/20 mL injection
Pentobarbital 1000 mg/20 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. It is recommended that the product be stored at 20-25°C…
Key facts
- Active ingredient (INN)
- Pentobarbital
- Brand
- Sold under the generic name
- Strength
- 1000 mg/20 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous
- Packs
- 1 vial of 20 mL
- Manufacturers
- Hikma PharmaceuticalsSagent Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. It is recommended that the product be stored at 20-25°C (68-77°F), however, brief excursions are permitted between 15-30°C (59-86°F). See USP controlled room temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N05CA01 Pentobarbital
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 April 2017
- Identifiers
- RxCUI 238090DailyMed set ID d375b92a-baa1-4d63-9ad1-1467dcfde7d5, e9f4b344-b092-4eec-b49d-d8cfe8ebc05dNDC 24201-010, 25021-676Application ANDA203619, ANDA206404
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 20 mL in 1 vial | 24201-010-20 | Hikma Pharmaceuticals | 1 October 2025 |
| 1 vial in 1 carton / 20 mL in 1 vial | 25021-676-20 | Sagent Pharmaceuticals | 19 April 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pentobarbital
Clinical summary
Pentobarbital is a prescription medicine. It is available as injection for intramuscular and intravenous use. MedsAcross supplies Pentobarbital for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PentobarbitalFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- pentobarbital sodium prescribing information (Sagent Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Pentobarbital 1000 mg/20 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.